Skip to main content
Erschienen in: World Journal of Surgery 9/2006

01.09.2006

Evaluation of the Cardiovascular Risk in Patients with Subclinical Cushing Syndrome Before and After Surgery

verfasst von: Yeşim Erbil, MD, Evin Ademoğlu, MD, Neşe Özbey, MD, Umut Barbaros, MD, Burcu Tulumoğlu Yanık, MD, Artur Salmaslioğlu, MD, Alp Bozbora, MD, Selçuk Özarmağan, MD

Erschienen in: World Journal of Surgery | Ausgabe 9/2006

Einloggen, um Zugang zu erhalten

Abstract

Background

The widespread use of ultrasound, computerized tomography, and magnetic resonance imaging has led to an increase in the number of incidental adrenal masses identified. Asymptomatic incidentally discovered adrenal masses may indicate that subclinical Cushing syndrome (SCS) is not uncommon. We aimed to evaluate the cardiovascular risk of patients with SCS before and after surgery.

Methods

An autonomous cortisol-producing tumor was detected in 11 of 94 patients with adrenal incidentaloma between 1995 and 2005. Twenty-eight patients suffering from classical Cushing syndrome (CS) associated with unilateral adrenocortical adenoma, who were treated at our department in the same period, served as a control group. Cardiovascular risk factors such as blood pressure, body mass index, and lipid profile were evaluated before and 1 year after surgery.

Results

The frequency of hypertension (61% versus 63%), obesity (46% versus 55%), diabetes mellitus (50% versus 36%), hypercholesterolemia (39% versus 36%), and low HDL cholesterol (28% versus 36%) were not significantly different between CS and SCS patients, respectively. Adverse cardiovascular risk profile improved 1 year after adrenalectomy in both groups, although the changes were not significant with respect to body mass index, frequency of diabetes, and hyperlipidemia in SCS patients. But frequency of systolic/diastolic hypertension decreased significantly in this group.

Conclusions

These findings indicate that the increased incidence of cardiovascular risk factors commonly observed in classical CS, is also present in SCS. Unilateral adrenalectomy does not always lead to significant improvements in cardiovascular risk profile in SCS.
Literatur
1.
Zurück zum Zitat Ross NS. Epidemiology of Cushing’s syndrome and subclinical disease. Endocrinol Metab Clin North Am 1994;23:539–546PubMed Ross NS. Epidemiology of Cushing’s syndrome and subclinical disease. Endocrinol Metab Clin North Am 1994;23:539–546PubMed
2.
Zurück zum Zitat Terzolo M, Osella G, Alì A, et al. Subclinical Cushing’s syndrome in adrenal incidentaloma. Clin Endocrinol (Oxf) 1998;48:89–97CrossRef Terzolo M, Osella G, Alì A, et al. Subclinical Cushing’s syndrome in adrenal incidentaloma. Clin Endocrinol (Oxf) 1998;48:89–97CrossRef
3.
Zurück zum Zitat Siren J, Tervahartiala P, Sivula A, et al. Natural course of adrenal incidentalomas: seven-year follow-up-up study. World J Surg 2000;245:579–582 Siren J, Tervahartiala P, Sivula A, et al. Natural course of adrenal incidentalomas: seven-year follow-up-up study. World J Surg 2000;245:579–582
4.
Zurück zum Zitat Terzolo M, Pia A, Alì A, et al. Adrenal incidentaloma: a new cause of the metabolic syndrome? J Clin Endocrinol Metab 2002;87:998–1003PubMedCrossRef Terzolo M, Pia A, Alì A, et al. Adrenal incidentaloma: a new cause of the metabolic syndrome? J Clin Endocrinol Metab 2002;87:998–1003PubMedCrossRef
5.
Zurück zum Zitat Nawar R, Aron D. Adrenal incidentalomas—a continuing management dilemma. Endocr Relat Cancer 2005;12:585–598PubMedCrossRef Nawar R, Aron D. Adrenal incidentalomas—a continuing management dilemma. Endocr Relat Cancer 2005;12:585–598PubMedCrossRef
6.
Zurück zum Zitat Mansmann G, Lau J, Balk E, et al. The clinically inapparent adrenal mass: update in diagnosis and management. Endocr Rev 2004;25:309–340PubMedCrossRef Mansmann G, Lau J, Balk E, et al. The clinically inapparent adrenal mass: update in diagnosis and management. Endocr Rev 2004;25:309–340PubMedCrossRef
7.
Zurück zum Zitat Braunstein GD. Management of the clinically inapparent adrenal mass. Ann Intern Med 2004;140:401–402 Braunstein GD. Management of the clinically inapparent adrenal mass. Ann Intern Med 2004;140:401–402
8.
Zurück zum Zitat Copeland PM. Management of the clinically inapparent adrenal mass. Ann Intern Med 2004;140:401PubMed Copeland PM. Management of the clinically inapparent adrenal mass. Ann Intern Med 2004;140:401PubMed
9.
Zurück zum Zitat Sippel RS, Chen H. Subclinical Cushing’s syndrome in adrenal incidentalomas. Surg Clin North Am 2004;84:875–885PubMedCrossRef Sippel RS, Chen H. Subclinical Cushing’s syndrome in adrenal incidentalomas. Surg Clin North Am 2004;84:875–885PubMedCrossRef
10.
11.
Zurück zum Zitat Bloom LS, Libertino JA. Surgical management of Cushing’s syndrome. Urol Clin North Am 1989;16:547–565PubMed Bloom LS, Libertino JA. Surgical management of Cushing’s syndrome. Urol Clin North Am 1989;16:547–565PubMed
12.
Zurück zum Zitat Barzon L, Fallo F, Sonino N, et al. Development of overt Cushing’s syndrome in patients with adrenal incidentaloma. Eur J Endocrinol 2002;146:61–66PubMedCrossRef Barzon L, Fallo F, Sonino N, et al. Development of overt Cushing’s syndrome in patients with adrenal incidentaloma. Eur J Endocrinol 2002;146:61–66PubMedCrossRef
13.
Zurück zum Zitat Charbonnel B, Chatal JF, Ozanne P. Does the corticoadrenal adenoma with “pre-Cushing’s syndrome” exist? J Nucl Med 1981;22:1059–1061PubMed Charbonnel B, Chatal JF, Ozanne P. Does the corticoadrenal adenoma with “pre-Cushing’s syndrome” exist? J Nucl Med 1981;22:1059–1061PubMed
14.
Zurück zum Zitat Rossi R, Tauchmanova L, Luciano A, et al. Subclinical Cushing’s syndrome in patients with adrenal incidentaloma: clinical and biochemical features. J Clin Endocrinol Metab 2000;85:1440–1448PubMedCrossRef Rossi R, Tauchmanova L, Luciano A, et al. Subclinical Cushing’s syndrome in patients with adrenal incidentaloma: clinical and biochemical features. J Clin Endocrinol Metab 2000;85:1440–1448PubMedCrossRef
15.
Zurück zum Zitat Royal College of Physicians. Obesity. A report of the Royal College of Physicians. J R Coll Physicians Lond 1983;17:5–65 Royal College of Physicians. Obesity. A report of the Royal College of Physicians. J R Coll Physicians Lond 1983;17:5–65
16.
Zurück zum Zitat Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults JAMA. 2001;285:2486–2497 Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults JAMA. 2001;285:2486–2497
17.
Zurück zum Zitat Kaye TB, Crapo L. The Cushing’s syndrome: an update on diagnostic tests. Ann Intern Med 1990;112:434–444PubMed Kaye TB, Crapo L. The Cushing’s syndrome: an update on diagnostic tests. Ann Intern Med 1990;112:434–444PubMed
18.
Zurück zum Zitat Angeli A, Terzolo M. Adrenal incidentaloma—a modern disease with old complications. J Clin Endocrinol Metab 2002;87:4869–4871PubMedCrossRef Angeli A, Terzolo M. Adrenal incidentaloma—a modern disease with old complications. J Clin Endocrinol Metab 2002;87:4869–4871PubMedCrossRef
19.
Zurück zum Zitat Bernini G, Moretti A, Iacconi P, et al. Anthropometric, haemodynamic, humoral and hormonal evaluation in patients with incidental adrenocortical adenomas before and after surgery. Eur J Endocrinol 2003;148:213–219PubMedCrossRef Bernini G, Moretti A, Iacconi P, et al. Anthropometric, haemodynamic, humoral and hormonal evaluation in patients with incidental adrenocortical adenomas before and after surgery. Eur J Endocrinol 2003;148:213–219PubMedCrossRef
20.
Zurück zum Zitat Faggiano A, Pivonello R, Spiezia S, et al. Cardiovascular risk factors and common carotid artery caliber and stiffness in patients with Cushing’s disease during active disease and 1 year after disease remission. J Clin Endocrinol Metab 2003;88:2527–2533PubMedCrossRef Faggiano A, Pivonello R, Spiezia S, et al. Cardiovascular risk factors and common carotid artery caliber and stiffness in patients with Cushing’s disease during active disease and 1 year after disease remission. J Clin Endocrinol Metab 2003;88:2527–2533PubMedCrossRef
21.
Zurück zum Zitat Emral R, Uysal AR, Asik M, et al. Prevalence of subclinical Cushing’s syndrome in 70 patients with adrenal incidentaloma: clinical, biochemical and surgical outcomes. Endocr J 2003;50:399–408PubMedCrossRef Emral R, Uysal AR, Asik M, et al. Prevalence of subclinical Cushing’s syndrome in 70 patients with adrenal incidentaloma: clinical, biochemical and surgical outcomes. Endocr J 2003;50:399–408PubMedCrossRef
22.
Zurück zum Zitat Torlontano M, Chiodini I, Pileri M, et al. Altered bone mass and turnover in female patients with adrenal incidentaloma: the effect of subclinical hypercortisolism. J Clin Endocrinol Metab 1999;84:2381–2385PubMedCrossRef Torlontano M, Chiodini I, Pileri M, et al. Altered bone mass and turnover in female patients with adrenal incidentaloma: the effect of subclinical hypercortisolism. J Clin Endocrinol Metab 1999;84:2381–2385PubMedCrossRef
23.
Zurück zum Zitat Tauchmanova L, Rossi R, Biondi B, et al. Patients with subclinical Cushing’s syndrome due to adrenal adenoma have increased cardiovascular risk. J Clin Endocrinol Metab 2002;87:4872–4878PubMedCrossRef Tauchmanova L, Rossi R, Biondi B, et al. Patients with subclinical Cushing’s syndrome due to adrenal adenoma have increased cardiovascular risk. J Clin Endocrinol Metab 2002;87:4872–4878PubMedCrossRef
24.
Zurück zum Zitat Reincke M, Nieke J, Krestin GP, et al. Preclinical Cushing’s syndrome in adrenal “incidentalomas”: comparison with adrenal Cushing’s syndrome. J Clin Endocrinol Metab 1992;75:826–832PubMedCrossRef Reincke M, Nieke J, Krestin GP, et al. Preclinical Cushing’s syndrome in adrenal “incidentalomas”: comparison with adrenal Cushing’s syndrome. J Clin Endocrinol Metab 1992;75:826–832PubMedCrossRef
25.
Zurück zum Zitat Mantero F, Terzolo M, Arnaldi G, et al. A survey on adrenal incidentaloma in Italy. J Clin Endocrinol Metab 2000;85:637–644PubMedCrossRef Mantero F, Terzolo M, Arnaldi G, et al. A survey on adrenal incidentaloma in Italy. J Clin Endocrinol Metab 2000;85:637–644PubMedCrossRef
26.
Zurück zum Zitat Mirallie E, Jafari M, Pattou F, et al. Outcome of non-operated adrenal masses in 126 patients observed from 1986 to 1999. Ann Chir 2001;126:212–220PubMedCrossRef Mirallie E, Jafari M, Pattou F, et al. Outcome of non-operated adrenal masses in 126 patients observed from 1986 to 1999. Ann Chir 2001;126:212–220PubMedCrossRef
27.
Zurück zum Zitat Terzolo M, Reimondo G, Bovio S, et al. Subclinical Cushing’s syndrome. Pituitary 2004;7:217–223PubMedCrossRef Terzolo M, Reimondo G, Bovio S, et al. Subclinical Cushing’s syndrome. Pituitary 2004;7:217–223PubMedCrossRef
Metadaten
Titel
Evaluation of the Cardiovascular Risk in Patients with Subclinical Cushing Syndrome Before and After Surgery
verfasst von
Yeşim Erbil, MD
Evin Ademoğlu, MD
Neşe Özbey, MD
Umut Barbaros, MD
Burcu Tulumoğlu Yanık, MD
Artur Salmaslioğlu, MD
Alp Bozbora, MD
Selçuk Özarmağan, MD
Publikationsdatum
01.09.2006
Erschienen in
World Journal of Surgery / Ausgabe 9/2006
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-005-0681-x

Weitere Artikel der Ausgabe 9/2006

World Journal of Surgery 9/2006 Zur Ausgabe

OriginalPaper

Book Reviews

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.